AwesomeCapital
Search This Blog
Monday, August 12, 2019
Fulcrum Therapeutics started at Overweight by Morgan Stanley
Target $29
https://www.benzinga.com/stock/FULC/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.